McGuireWoods Consulting announced today it has opened a Tallahassee office with the arrival of veteran lobbyists Sean Stafford, Rhett O’Doski and Ryder Rudd.
Tucker Martin will join the MWCAdvocacy team next week as a senior vice president, assisting clients across a variety of industries nationwide with media relations, strategic communications, and grassroots initiatives.
McGuireWoods Consulting is delighted to announce the return of Missy Neff to its Richmond team as a senior vice president for MWCAdvocacy, handling legislative affairs. As part of the MWCAdvocacy team, she will support clients along with a team of additional communications, grassroots, and digital professionals.
McGuireWoods Consulting today announced that Gena McGroarty was promoted to vice president of MWCAdvocacy effective January 1.
The legislature was particularly busy this week as interim committees worked to approve their legislative reports and recommendations ahead of the May 16 opening day of the 2018 short session. Numerous pieces of draft legislation came out of multiple committees, including new proposed regulations regarding transportation funding, education, occupational licensing, and school safety. Those drafts are expected to be filed early on in the short session.
Illinois legislative news for the week of April 27, 2018.
Your weekly North Carolina political news report.
This Week: Opioid legislation advances in Energy and Commerce and Senate HELP Committees, CMS releases MA encounter data to the public for the first time, and FDA announces a slew of new initiatives.
The General Assembly kept up a steady pace of meetings this week. Legislators covered student health improvements, opioid crisis management options, education finance, river quality, and judicial redistricting. More legislative recommendations came out as the legislature prepares for the short session to kick off next month.
GA-18-380: This report examines the progress the progress the Veterans Health Administration (VHA) has made improving opioid safety through its Opioid Safety Initiative (OSI).
An overview of the upcoming week in Congress from the McGuireWoods Consulting Tax Policy Update Team.
This month, President Trump announced his plan to lower drug prices. The plan does not call for a major overhaul of drug companies’ pricing practices, but does include some proposals that they oppose. Much of Trump’s plan is in the form of suggested actions, and it will take time for actual detailed proposals to be put forward.